DJ BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
March 24, 2021 06:48 ET (10:48 GMT)
DJ BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
March 24, 2021 06:48 ET (10:48 GMT)